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The long flexuous virions of the Closteroviridae have a unique
bipolar architecture incorporating two coat proteins, with most of
the helical nucleocapsid encapsidated by the major coat protein
(CP) and a small portion of one end encapsidated by the minor coat
protein (CPm). It is not known whether CPm encapsidates the
genomic RNA and, if so, which end and what effects transition
between the two coat proteins. Two other virus-encoded proteins,
an HSP70 homolog (HSP70h) and an61-kDa protein, are required
to augment virion assembly. In this work, we examine the in vivo
encapsidation of Citrus tristeza virus by its CPm in the absence of
CP. In the absence of other assembly-related proteins, CPm pro-
tected a family of 5 coterminal RNAs, apparently because of
pausing at different locations along the genomic RNA. Most of the
nucleocapsids formed by CPm were short, but a few were full-
length and infectious. Mutations within the 5 nontranslated
region demonstrated that the CPm origin of assembly overlaps the
previously described conserved stem-and-loop structures that
function as a cis-acting element required for RNA synthesis. Thus,
in the absence of CP, the CPm encapsidation is initiated from the
5 end of the genomic RNA. Coexpression of HSP70h and the p61
protein with CPm in protoplasts restricted encapsidation to the 5
630 nucleotides, which is close to the normal boundary of the
bipolar virion, whereas the presence of either HSP70h or the p61
protein alone did not limit encapsidation by CPm.
The principle functions of the virion are to protect the virusgenome and to facilitate its transmission from host to host or
within the host. Viruses of animals have a general requirement
for a precise interaction between the virion and the host cell
membrane to allow entry. Thus, the virion might have specific
proteins to provide that interaction. A requirement for many
plant viruses is a precise interaction with a vector: arthropod,
nematode, or fungus. Some viruses have both animal and plant
hosts. Virions range from simple, consisting of only one coat
protein, which self-assembles with the viral RNA, to extraordi-
narily complex, involving multiple structural proteins along with
numerous accessory proteins, which may be scaffolding proteins
or chaperones (1, 2). Although virions exhibit a wide range of
structural diversity, size, composition, and complexity, nucleo-
capsids, in general, are of two basic types of symmetry: helical or
icosahedral. Many plant viruses have virions consisting of helical
nucleocapsids, which are open structures, usually consisting of a
single-coat protein with regular stacking around a nucleic acid in
a constant relationship of amplitude and pitch. Helical virions
can be rigid or flexible, depending on the coat protein, and
virion lengths are determined by the length of the nucleic acid
molecule.
The long flexuous virions of Citrus tristeza virus (CTV) and
other viruses of the Closteroviridae family have a helical archi-
tecture consisting of two coat proteins. The major coat protein
(CP) encapsidates most (95%) of the virion (the ‘‘body’’) in a
manner similar to that of other helical viruses, but the second
(minor) coat protein (CPm) encapsidates the other end (the
‘‘tail’’), resulting in ‘‘rattlesnake-like’’ virions (3–5). It is not
known which end of the genome is encapsidated by CPm. The
location of the tail was examined previously by shearing virions
of the related Beet yellows virus (BYV) and by using antibodies
to CPm to enrich broken particles that appeared to have more
5 sequences (6), but these results were not conclusive. In fact,
it is not resolved whether CPm encapsidates any RNA. Alzh-
anova et al. (7) proposed a model for BYV in which CP
encapsidates the entire genomic RNA, whereas the CPm tail
portion encapsidates no RNA. If CPm does encapsidate one end
of the genomic RNA, no understanding of what defines the
transition between CPm and CP exists.
CTV has a positive-stranded RNA genome of20 kb with the
5 half encoding replicase-associated domains that are ex-
pressed by a polyprotein. The internally positioned genes, which
are not required for replication and are thought to be involved
in host interactions, virion assembly, vector specificity, and
movement within the plant, are expressed from 3 coterminal
subgenomic mRNAs (8–10). The in vitro assembly of CTV has
not been developed. By genetically manipulating the virus in
Nicotiana benthamiana protoplasts, we previously demonstrated
that two additional virus-encoded proteins, in addition to the
two coat proteins, are required for efficient assembly of CTV
virions, apparently by functioning together (11). One is a ho-
molog of the ubiquitous HSP70 proteins (HSP70h), which has
chaperone-like characteristics, and the other is a 61-kDa protein.
Homologs of these two proteins of related closteroviruses have
been found to be tightly attached to virions (5, 12, 13), but it is
not known whether they augment the assembly process or
whether they are minor structural components. Additionally, we
found that two conserved stem-and-loop (SL) structures within
the 5 nontranslated region (NTR) (14), which are cis-acting
elements necessary for replication, also appear to be involved in
virion formation (15).
In this study, we continued dissection of the virion assembly
process by examining the encapsidation of a minimal CTV
replicon containing the CPm gene in the absence of CP, with or
without HSP70h andor p61. We show that, at least in the
absence of CP, the tail covers the 5 end of the genome and that
initiation of assembly by the CPm occurs within the 5 NTR, in
a region that apparently overlaps the previously characterized
replication-specific cis-acting element. The CPm in the absence
of the other assembly-related proteins was able to encapsidate
and protect the entire genomic RNA, albeit at reduced levels.
However, the combination of HSP70h, p61, and CPm restricted
encapsidation to the 5 630 nucleotides.
Materials and Methods
Construction of Plasmids. The full-length cDNA clone of CTV,
pCTV9R (16, 17), was the basis of all constructs. The nucleotide
Abbreviations: CP, major coat protein; CPm, minor coat protein; CTV, Citrus tristeza virus;
BYV, Beet yellows virus; NTR, nontranslated region; dpi, days after inoculation; SL, stem-
and-loop; sgRNA, subgenomic RNA.
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numbering and sequences of the primers used in this study are
according to GenBank (accession no. AY170468) (17). DNA
fragments consisting of nucleotides 15115–16058, 13537–16058,
11658–16058, or a DNA fragment comprising nucleotides
11658–13813 and 15115–16058 in tandem, were amplified with
forward and reverse primers containing flanking XhoI and PstI
restriction sites, digested with XhoI and PstI, and ligated into a
similarly digested CTV-p23 replicon (18) to obtain CTV-CPm,
CTV-p61-CPm, CTV-HSP70h-p61-CPm, and CTV-HSP70h-
CPm, respectively. An additional nonviral cytidylate was intro-
duced at nucleotide 15383 by using overlap extension PCR (19)
to disrupt the reading frame of CPm ORF in CTV-CPm to
obtain CTV-CPmFS. The CTV-CP replicon containing the CP
ORF under its own controller element plus the p23 ORF has
been described (18).
The 5 NTR mutations in the CTV-Cla replicon (15) were
transferred to CTV-CPm and CTV-CP by removing the SphI (at
nucleotide 1660) to NotI (engineered at the 3 end; ref. 16)
fragment, which was ligated into the similarly digested pCTV-
Cla constructs containing the 5 NTR mutations (15). The
mutations were confirmed by nucleotide sequencing.
In Vitro Transcription, Inoculation of Protoplasts, and Northern Blot
Analysis of RNAs. Capped (m7G) in vitro-produced RNA tran-
scripts were used for polyethylene glycol-mediated transfections
of N. benthamiana leaf protoplasts (1 106) as described (16).
Protoplasts were harvested at 4 days after inoculation (dpi) to
isolate total RNA or to purify nucleocapsids. RNA was analyzed
by Northern blot hybridizations by using four different ribo-
probes, positive- and negative-stranded RNA-specific probes
corresponding to the 5 or 3 ends of CTV (16, 20), and
quantified by scanning and densitometry by using OS-SCAN
(Oberlin Scientific, Oberlin, OH). All experiments were re-
peated three to five times with each replicon.
Isolation and Analysis of Nucleocapsid-Like Particles. Several batches
(6–14) of protoplasts were combined; the frozen and thawed
protoplast pellets were suspended in 40 mM sodium phosphate
buffer, pH 8.2, and clarified by centrifugation at 4,000 rpm for
5 min. The pooled supernatants (10 ml) were layered on a
gradient of 1 ml of 70% sucrose and 0.25 ml each of 50% and
20% sucrose in sodium phosphate buffer and were centrifuged
at 200,000  g at 4°C for 75 min in a SW41 rotor. The upper 0.5
ml of 70% sucrose was collected and used to visualize nucleo-
capsids by electron microscopy or for protein or RNA analyses.
Alternatively, the clarified sap (7 ml) from 4 dpi protoplasts
was layered on cesium sulfate-sucrose step gradients (1 ml each
of 0%, 15%, 22.5%, and 30% cesium sulfate in 10% sucrose) and
was centrifuged at 200,000  g for 2.5 h at 8°C in a SW41 rotor.
The bottom 0.95 ml was discarded, and the next 1.5 ml was
collected and diluted to 2.5 ml with sodium phosphate buffer,
layered on a preformed cesium sulfate-sucrose density gradient
(3 ml each of 15%, 22.5%, and 30% sucrose in 10% cesium
sulfate), and centrifuged at 200,000 g for 2.5 h at 8°C in a SW41
rotor. The bottom 3.0 ml were discarded, and the nucleocapsids
present in the next 4.0 ml were diluted to 6 ml with sodium
phosphate buffer, then precipitated with 4% polyethylene glycol
8000 in the presence of 0.2 N sodium chloride on ice for 1 h, and
centrifuged at 15,000 rpm for 15 min at 4°C.
The passage of progeny virions in crude sap between proto-
plasts, the serological specific electron microscopy, immunogold
labeling of CPm virions, and Western immunoblots were de-
scribed (11, 21, 22).
Mapping the 3 End of the RNA Encapsidated by CPm. The RNA
isolated from nucleocapsids purified by cesium sulfate-sucrose
density gradient centrifugation was denatured at 90°C, polyad-
enylated at the 3 terminus, cloned as described (23), and
sequenced at the Interdisciplinary Center for Biotechnology
Research DNA sequencing core facility of the University of
Florida (Gainesville).
Results
CPm Can Protect the Entire Genomic RNA. In the near-full-length
virus, CPm in the presence of both HSP70h and p61 did not
assemble detectable amounts of full-length nucleocapsids nor
facilitate passage to a new set of protoplasts (11). Here, we
examined the ability of CPm to form nucleocapsids in the
absence of other assembly-related proteins. For this purpose, we
used a minimal replicon, CTV-p23 (18), which contains the 5
NTR, ORFs 1a and 1b (replicase genes), the p23 gene, which is
required to inhibit minus-stranded RNA synthesis so that suffi-
cient single-stranded RNA is produced as substrate for assembly,
and finally the 3 NTR. This replicon was designed to express
different combinations of assembly-associated genes to be as-
sayed for nucleocapsid production. CPm was expressed by
replicon CTV-CPm that had the CPm gene inserted between
ORF 1b and the p23 gene (Fig. 1Ab). CTV-CPmFS, which
contained a 1 frameshift mutation in CPm ORF, was a
negative control (Fig. 1 Ac). In vitro-produced RNA transcripts
of CTV-CPm, CTV-CPmFS, or wild-type CTV (CTV9R) (Fig.
1Aa; ref. 17) were used to inoculate N. benthamiana protoplasts,
and their ability to form nucleocapsids was examined at 4 dpi.
CTV-CPm nucleocapsids, partially purified by centrifugation
through a 70% sucrose cushion and examined by serological
specific electron microscopy, were mostly short particles ranging
from 70 to 800 nm in length, plus a few larger particles with
a length (1,400 nm) expected for that of the complete CTV-
CPm genomic RNA (Fig. 1C Upper). We did not find any virus
particles from CTV-CPmFS-infected protoplasts, suggesting
that the particles observed were produced by the encapsidation
of different lengths of the replicon RNA by CPm. Immunogold
labeling using a CPm-specific polyclonal antiserum decorated
the surface of both the small and the large particles (Fig. 1C
Lower), confirming that the particles were constituted by CPm.
Protein from the partially purified nucleocapsids from CTV-
CPm also strongly reacted with CPm antiserum in Western
immunoblots (Fig. 1D, lane b), but not with CP antiserum (data
not shown). Nucleocapsid protein extracts from CTV-CPmFS
and mock-inoculated protoplasts did not react with CPm anti-
serum (Fig. 1D, lanes c and m).
We previously developed a rigorous assay for virions (infec-
tious nucleocapsids) by examining their ability to be passaged in
crude sap from one set of protoplasts to another set (11). This
assay was based on two observations. First, the free unencapsi-
dated RNA was degraded under the conditions of incubation in
crude extracts. Second, virions are 10,000 times more infec-
tious to protoplasts than free viral RNA, apparently because of
their ability to be inserted into protoplasts (22). Incomplete
nucleocapsids failed to be passaged under these conditions (11).
At 4 dpi, the progeny nucleocapsids were extracted as crude sap
from the infected protoplasts and then transfected to a new set
of protoplasts. Fig. 1B shows a Northern blot hybridization
demonstrating the levels of replication in protoplasts infected by
the in vitro produced RNA transcripts compared with their
progeny nucleocapsids. The progeny nucleocapsids from the
wild-type virus (CTV9R) were efficiently passaged to the next
set of protoplasts (Fig. 1Ba). The progeny nucleocapsids from
the CTV-CPm replicon also were passaged to the next set of
protoplasts, although at much reduced levels (Fig. 1Bb) appar-
ently due to a reduced number of protoplasts infected by the few
full-length nucleocapsids formed by CPm. Yet, these data dem-
onstrate that some nucleocapsids formed by only CPm were
infectious. No passage of CTV-CPmFS to the next set of
protoplasts was detectable (Fig. 1Bc).
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Taken together, these data suggest that the CPm, in the
absence of other assembly-related proteins, was able to form a
few full-length, infectious nucleocapsid (replicon size), but most
particles were smaller nucleocapsids of various sizes.
CPm Initiates Encapsidation from the 5 End of the Genome. CTV
produces large quantities of double-stranded RNAs (18) that
contaminate nucleocapsid preparations after sucrose density
gradient centrifugation, obscuring detection of encapsidated
RNAs. To analyze encapsidated RNAs, we had to adapt a system
that stringently purifies nucleocapsids from unencapsidated
RNAs, particularly double-stranded RNAs. We found that two
cycles of cesium sulfate-sucrose density gradient centrifugation
effectively eliminated unencapsidated RNAs from nucleocap-
sids. The nucleocapsid fractions from the cesium sulfate-sucrose
gradient centrifugations of CTV-CPm-infected protoplasts were
analyzed for encapsidated RNAs by Northern blot hybridization
with positive- or negative-stranded RNA-specific probes corre-
sponding to the 5 or 3 ends of CTV (Fig. 2A). The 5- or
3-specific negative-stranded RNA probe did not hybridize with
any small RNAs that would correspond with the observed small
nucleocapsids. An RNA of the size of the p23 subgenomic RNA
(sgRNA) hybridized with the 3 positive-stranded RNA-specific
probe suggesting that a small amount of this abundant 3-
terminal sgRNA was encapsidated by CPm (Fig. 2 A, lane 10).
However, most of the RNA found occurred as a ladder of RNAs
that hybridized with the 5 positive-stranded RNA-specific probe
(Fig. 2 A, lane 4). Because these RNAs have a common 5 end,
the data suggest that the CPm, in the absence of other assembly-
related proteins, initiated encapsidation from the 5 end of the
replicon RNA but paused at different locations during the
assembly process (Fig. 2B). The data also suggest that the 3
regions of the replicon RNAs remained unencapsidated and
were degraded during the extensive purification process.
The Origin of Assembly of CPm Is Located in the 5 NTR. The 107
nucleotides of the 5 NTR are folded by MFOLD (24) into two
Fig. 1. (A) Genomic organization of wild-type CTV (CTV9R) (a) and replicons CTV-CPm (b) and CTV-CPmFS (c). The open boxes represent ORFs and their
translation products. PRO, papain-like protease; MT, methyltransferase; HEL, helicase; RdRp, RNA-dependent RNA polymerase. (B) Northern blot hybridizations,
probed with a 3 positive-stranded RNA-specific probe, of RNAs from protoplasts inoculated with in vitro produced transcripts (TR) or progeny nucleocapsids
(V) in crude sap by CTV9R (a), CTV-CPm (b), or CTV-CPmFS (c). Arrowheads indicate the position of genomic RNA. Wild-type CTV9R 3 sgRNAs are indicated on
the left. The position of CPm and p23 sgRNAs of replicons are shown. (C) Negative-stained electron micrographs of CTV-CPm large and small nucleocapsids
(Upper) and nucleocapsids treated with CPm-specific antibodies and decoration with 10-nm gold particles (Lower). (Bar  100 nm.) (D) Western immunoblot
analyses of proteins of partially purified nucleocapsids from protoplasts transfected with CTV-CPm (lane b), CTV-CPmFS (lane c), or mock-inoculated protoplasts
(lane m). Arrow indicates the position of CPm-specific protein band.
Fig. 2. (A) Northern blot hybridization analyses of RNAs from nucleocapsids
purified from protoplasts at 4 dpi with no RNA (lanes 2, 5, 8, and 11),
CTV-CPmFS (lanes 3, 6, 9, and 12), or CTV-CPm (lanes 4, 7, 10, and 13) hybridized
with strand-specific riboprobes. Wild-type CTV 3 sgRNAs (lane 1) are size
markers on the left. Copurified double-stranded RNAs are indicated with
asterisks. (B) Schematic diagram of CTV-CPm showing various sized 5-
coterminal RNAs encapsidated by CPm.






stem-loop structures (SL1 and SL2) separated by a 5-nt spacer
region and nonfolding regions on both sides (ref. 15 and Fig. 3B).
Using mutational analysis of the 5 NTR, we found that these
secondary structures functioned as a cis-acting element required
for replication (15). However, certain mutations in the 5 NTR
that allowed replication did not allow formation of virions
capable of being passaged from protoplast to protoplast (15).
The previous results plus those presented here, demonstrating
that encapsidation involves the 5 end, led us to examine the
effect of these 5 NTR mutations on initiation of nucleocapsid
formation by CPm. We recreated in CTV-CPm seven of the
mutations previously found that allowed continued replication at
40–100% of wild-type levels (Fig. 3B; ref. 15). These mutations
included deletion of the 5 9 nucleotides (mutant a); compen-
satory mutations in the top (mutant b) and bottom (mutant c)
of SL1 and the bottom of SL2 (mutant e); insertion of seven
nonviral nucleotides at the spacer (mutant d); deletion of the top
portion of SL2 (mutant f); and deletion of nucleotides 97–107
between the structure and the start codon of ORF 1a (mutant
g) (Fig. 3B). CTV-CPmFS was the negative control. Mutants a,
b, e, and f replicated in N. benthamiana protoplasts, accumulat-
ing RNAs at 60–100% of the levels of wild-type CTV-CPm,
with mutants c, d, and g accumulating at lower levels of
40–50% (Fig. 3D Top). Nucleocapsids were partially purified
by centrifugation through a 20% sucrose cushion and the North-
ern hybridization blots demonstrated that only mutants b and e
encapsidated the 5 coterminal RNAs (Fig. 3D Bottom). Also,
Western immunoblot analyses using CPm-specific polyclonal
antiserum confirmed that CPm nucleocapsids were formed only
by mutants b and e (Fig. 3D Middle). Deletions in 5 and 3
nonfolding regions (mutants a and g), mutations in the lower
part of SL1 (mutant c), insertion at the spacer region (mutant d),
and deletion of SL2 top portion (mutant f) prevented encapsi-
dation of the viral RNA by CPm. The compensatory mutations
in the top portion of SL1 (mutant b) and bottom portion of SL2
(mutant e) did not prevent encapsidation by CPm. These results
suggested that the origin of assembly sequence for the encapsi-
dation of RNA by CPm is located in the 5 NTR.
The Combination of HSP70h and p61 Restricts CPm Encapsidation to
the 5 End. We next examined the effects of HSP70h andor the
p61 protein on encapsidation by CPm. The HSP70h and p61
genes, independently (CTV-HSP70h-CPm or CTV-p61-CPm) or
together (CTV-HSP70h-p61-CPm), were ligated into CTV-CPm
and examined for nucleocapsid production (Fig. 4A). Nucleo-
capsids from protoplasts at 4 dpi were purified through two
cycles of cesium sulfate-sucrose density gradient centrifugation;
RNAs were extracted and analyzed by using 5 or 3 positive- and
negative-stranded RNA-specific probes.
The CPm replicons containing either HSP70h (CTV-HSP70h-
CPm) or p61 (CTV-p61-CPm) produced particles containing a
ladder of positive-stranded RNAs that hybridized with the 5
positive-stranded RNA-specific probe, similar to that of the
CTV-CPm replicon (Fig. 4B, lanes 3–5). A band corresponding
to p23 sgRNA also was detected by the 3 positive-stranded
RNA-specific probe (Fig. 4B, lanes 15–17). However, the rep-
licon containing the combination of HSP70h and p61 plus CPm
(CTV-HSP70h-p61-CPm) produced particles with a different
RNA profile. Only one RNA species of 650 nucleotides was
found that hybridized with the 5 positive-stranded RNA-specific
probe (Fig. 4B, lane 6). Additionally, the 3 positive-strand-
specific p23 sgRNA was not found (Fig. 4B, lane 18). When
visualized by serological specific electron microscopy, CTV-
HSP70h-p61-CPm produced small uniform particles of 70 nm
in length (Fig. 4C). These data suggest that, in the absence of CP
and the presence of HSP70h, p61, and CPm, encapsidation was
restricted to the 5 650 nucleotides of genomic RNA.
Western immunoblot analysis of purified nucleocapsids re-
vealed that only a slight increase occurred in the total amount of
CPm associated with particles from the replicon containing CPm
plus both HSP70h and p61 compared with that of CPm replicons
with CPm alone or CPm with either HSP70h or p61 (data not
presented). This marginal increase in assembled CPm in the
Fig. 3. The effect of 5 NTR mutations on encapsidation by CPm and CP. (A) Schematic map of CTV-CPm and CTV-CP. (B) The predicted secondary structure of
the 5 NTR of CTV T36 showing the SL structures, SL1 and SL2, separated by a 5-nt spacer and nonfolding regions (NFR) on both sides. Mutations a, f, and g are
deletions; mutations b, c, and e are compensatory mutations; and mutation d is an insertion. Accumulation of 3 positive-stranded RNAs from 5 NTR mutants
(a–g) of CTV-CP (C Upper) or CTV-CPm (D Top). Western immunoblot analyses of proteins from partially purified nucleocapsids from 5 NTR mutants of CTV-CP
(C Lower) or CTV-CPm (D Middle) are shown. Analyses of encapsidated 5 coterminal RNAs from 5 NTR mutants of CTV-CPm (D Bottom). Arrowheads indicate
the position of genomic RNA. The position of CP, CPm, and p23 sgRNAs are shown in Northern blots. M, mock-inoculated protoplasts; WT, wild-type replicon;
V, virions from full-length wild-type CTV; FS, CTV-CPmFS.
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presence of both HSP70h and p61, compared with the 50- to
70-fold increase in the amount of the small 5 RNA (650
nucleotides) that was encapsidated, was probably due to CPm
encapsidating extended areas of fewer RNAs in the absence of
both HSP70h and p61.
CPm Encapsidates the 5 630 Nucleotides of the Genomic RNA. The
replicon CTV-HSP70h-p61-CPm encapsidated large amounts of
a relatively uniform RNA of 650 nucleotides (Fig. 4B, lane 6).
We isolated these encapsidated RNAs from nucleocapsids pu-
rified by two cycles of cesium sulfate-sucrose density gradient
centrifugation from CTV-HSP70h-p61-CPm-infected proto-
plasts to determine their 3 termini. The RNA was poly(A)-
tailed, reverse-transcribed, PCR-amplified, and cloned. Restric-
tion enzyme digestion resulted in two uniform sizes of inserts:
about 80% large and 20% small. We sequenced 15 clones with
the larger insert and 5 clones with the smaller insert. Ambiguities
resulted when the apparent terminus was adjacent to a 3
adenylate residue in the CTV sequence, because we could not
distinguish whether the adenylate(s) resulted from the sequence
or the poly(A) tail. Nine of the large inserts had identical 3
termini at nucleotides 627, 628, or 629 with six at nucleotides 630
or 631 (Fig. 5). Three of the small inserts terminated after
nucleotide 611 and one each after nucleotide 612 and nucleotide
613 or 614 (Fig. 5). Thus, encapsidation of the genomic RNA in
the presence of CPm, HSP70h, and p61 stopped near nucleotides
627–631, occasionally stopping at nucleotides 611–614. It should
be noted that both stopping points occur near a series of four
cytidylates (CCCC) (Fig. 5).
The 5 NTR Mutations Do Not Affect Assembly by CP. To examine the
effect of 5 NTR mutations on the translatability of the inserted
gene, the stability of the RNAs, and their effect on encapsidation
by CP, we introduced the 5 NTR mutations (a–g) into CTV-CP
(Fig. 3A). The CP, in the absence of the other assembly-
associated proteins, encapsidates the CTV-CP replicon by form-
ing various sizes of nucleocapsids (T.S. and W.O.D., unpublished
data). The 5 NTR mutants of CTV-CP accumulated levels of
progeny RNAs similar to that of the corresponding 5 NTR
mutants of CTV-CPm (Fig. 3C Upper). Mutants a, b, e, f, and g
accumulated CP in particles at levels approximately similar to
that of wild-type CTV-CP (Fig. 3C Lower), whereas mutants c
and d accumulated levels of CP in nucleocapsids at40–50% of
the wild-type levels, generally in proportion to their levels of
replication (Fig. 3C Lower). Moreover, the progeny nucleocap-
sids in crude extracts from the 5NTR mutants of CTV-CP were
successfully passaged to the next set of protoplasts (data not
presented), demonstrating that the 5 NTR mutations did not
appreciably affect CP encapsidation.
Discussion
We showed that CPm, at least in the absence of CP, does
encapsidate genomic RNA, the tail (perhaps it should be called
the ‘‘head’’) occurs at the 5 end, and CPm initiates encapsida-
tion within the 5 NTR. The 5 halves of different CTV isolates
vary considerably in sequence similarity, in particular, within the
5 NTR where similarities are as low as 42% (25). Yet, it was
noticed that all strains were predicted to retain two similar
adjacent SL structures (14), in particular, in the positive strands
(15). We examined these putative SL structures and found that
retention of the structures was important for the ability of the
RNA to be replicated, but this cis-acting element tolerated
considerable sequence modification (15). Here we found that the
element required to initiate assembly of the CPm overlaps this
area. Deletions beyond each side of the replication-dependent
cis-acting element in nonfolded areas prevented initiation of
encapsidation by CPm as did some mutations within the double
SL region. Several of the compensatory mutations with sequence
changes that allowed replication to continue prevented nucleo-
capsid assembly. Thus, the CPm origin of assembly appears to be
larger and more sequence-specific than the overlapped replica-
tion element.
The combination of HSP70h and p61 along with CPm dra-
matically stopped encapsidation between nucleotides 611 and
631. The BYV HSP70h has been shown to have some in vitro
biochemical characteristics of chaperones. The N-terminal do-
main was shown to have ATPase activity as expected for an
HSP70 chaperone, but its C-terminal region did not bind to
unfolded proteins (26). Additionally, mutation of the putative
ATPase active site inhibited CTV virion assembly (11). Thus,
one possible function of the HSP70h would be a chaperone
function, perhaps to assist in the proper folding of one or both
Fig. 4. The combination of HSP70h and p61 along with CPm restricts
encapsidation to 5 650 nucleotides of genomic RNA. (A) Schematic diagram
of replicons. (B) Northern blot hybridizations of CPm-encapsidated RNAs
purified from protoplasts at 4 dpi with no RNA (lanes 1, 7, 13, and 19),
CTV-CPmFS (lanes 2, 8, 14, and 20), CTV-CPm (lanes 3, 9, 15, and 21), CTV-
HSP70h-CPm (lanes 4, 10, 16, and 22), CTV-p61-CPm (lanes 5, 11, 17, and 23),
or CTV-HSP70h-p61-CPm (lanes 6, 12, 18, and 24) by using strand-specific
riboprobes. Asterisks indicate double-stranded RNAs copurified with nucleo-
capsids. (C) Electron micrographs of representative negative-stained nucleo-
capsid-like particles from CTV-HSP70h-p61-CPm replicon. (Bar  50 nm.)
Fig. 5. Mapping the 3 termini of RNAs encapsidated by CPm in the presence
of HSP70h and p61 proteins. Arrows show the number of clones terminated at
different locations in the genomic RNA sequence. Brackets indicate the pos-
sible alternate 3 termini due to the presence of adenylates after nucleotides
613, 627, and 630.






coat proteins. Cellular HSP70s have been implicated in the
assembly of diverse groups of animal viruses (27–31), yet ho-
mologs of HSP70h and p61 have been shown to be tightly
attached to virions of other members of the Closteroviridae
family (5, 12, 13). Does this suggest that they function as minor
structural proteins rather than enhancing the assembly process?
It is possible that one or both proteins of HSP70h and p61 bind
to the transition zone to prevent progression of encapsidation by
CPm.
We previously examined assembly of CTV virions by making
mutations in 3 genes and identified four genes needed for
efficient production of nucleocapsids (11). Using the full-length
virus with the deletion of the CP gene (leaving the CPm,
HSP70h, and p61 genes intact) resulted in only a few small
particles. That result is consistent with the small nucleocapsids
produced by the replicon expressing CPm, HSP70h, and p61
proteins. It is possible that nucleocapsid assembly by these three
proteins, in the absence of CP, differs from wild-type virion
assembly. However, the efficiency of formation of these short
particles and their approximation to the size of the tail of
wild-type virions (3, 4) suggest that this subset of encapsidation
reflects the normal bipolar virion assembly.
So, what is the advantage of the 5 end of the genome being
encapsidated by a different coat protein? What function does
this architecture provide that is not provided by other helical
virions composed of only one coat protein? It is common for
cell-to-cell andor long-distance movement of plant viruses to
require the ability of virion formation. The tail structure of BYV
has been proposed as a ‘‘specialized device’’ required for move-
ment functions (7, 13). However, it is unclear how a minor coat
protein on the 5 end of the genome would affect movement.
These bipolar helical virions are transmitted by insect vectors in
a semipersistent manner (32). Perhaps the tail has specific
affinity for the mouth parts of vectors (5). Another possibility is
that the tail assists in disassembly and initiation of infection. The
two coat proteins of helical viruses could allow different regions
of the virions to have different states of equilibrium: one coat
protein could bind more tightly, providing more stability of the
virion in different environments, whereas the coat protein at the
5 end of the genome could be looser, allowing easy initiation of
translation after entering a cell. An understanding of the clos-
terovirus virion should allow us to better understand the biology
of this unique group of viruses.
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